USE OF CORAXAN IN PATIENTS WITH ACUTE CORONARY SYNDROME


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Addition of Coraxan in a daily dose of 10-15 mg to standard antianginal therapy in acute coronary syndrome patients prone to hypotension and, in this connection, the complexity of titration of β-adrenoblockers promoted an increase in exercise endurance, a reduction in the number of angina attacks, achievement of normocardia, without additionally lowering blood pressure, as well as a decrease in the frequency of ventricular and supraventricular arrhythmias. The test drug was noted to be well tolerated.

Full Text

Restricted Access

About the authors

E. Derevyannykh

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University; Research Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical Sciences

L. Pollkarpov

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University; Research Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical Sciences

R. Yaskevlch

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University; Research Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical Sciences

E. Kozlov

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University; Research Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical Sciences

N. Balashova

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University; Research Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical Sciences

E. Karpukhina

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University; Research Institute of Medical Problems of the North, Siberian Branch, Russian Academy of Medical Sciences

References

  1. Амосова Е.Н. Метаболическая терапия повреждения миокарда, обусловленного ишемией: новый подход к лечению ИБС и сердечной недостаточности // Український кардіологічний журнал. - 2000; 4: 85-92.
  2. Арутюнов, П. Статины - острые коронарные синдромы. Мы на пороге нового стандарта лечения // Клин. фармакол. и тер. - 2001; 10: 2-8.
  3. Новые подходы к диагностике и формулировке диагноза «Инфаркт миокарда». Рекомендации Европейского кардиологического общества. 2000; -22 с.
  4. Onwuanyi A., Clarke A., Vanderbush E. Cardiovascular disease mortality // J. Natl. Med. Assoc. - 2003; 95 (12): 1146-51.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2013 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies